跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ANTI-DANDRUFF ANTIPELLICULAIRE 2 IN 1 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ANTI-DANDRUFF ANTIPELLICULAIRE 2 IN 1
Authorized
STANDARD
ANTI-DANDRUFF ANTIPELLICULAIRE 2 IN 1
l' oreal canada
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2c728aac064a649f
Company
l' oreal canada
Type
Standard
Approval Details
Approval Id
2c728aac064a649f
Drug Approval Canada Name
ANTI-DANDRUFF ANTIPELLICULAIRE 2 IN 1
Product Name
ANTI-DANDRUFF ANTIPELLICULAIRE 2 IN 1
Status
Marketed
Status Date
2023-02-01
Original Market Date
2023-02-01
Din
02508184
Drug Class
Human
Dosage Form
Shampoo
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:04.92
Atc Original
D11AX12 PYRITHIONE ZINC
Atc Name
d 11 ax 12
Aig Number
0108628001
Company Name
l' oreal canada
Company Address
4895 Rue Hickmore, Montreal, Quebec, Canada, H4T 1K5
Active Ingredients
PYRITHIONE ZINC
1 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2c728aac064a649f
Type
Standard
Back to Health Canada Approvals